AVENOSO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 1.433
AS - Asia 1.303
EU - Europa 686
SA - Sud America 342
Continente sconosciuto - Info sul continente non disponibili 64
AF - Africa 31
Totale 3.859
Nazione #
US - Stati Uniti d'America 1.344
SG - Singapore 440
IT - Italia 434
BR - Brasile 277
CN - Cina 276
BD - Bangladesh 205
VN - Vietnam 130
HK - Hong Kong 99
FR - Francia 52
TR - Turchia 43
GB - Regno Unito 41
RU - Federazione Russa 39
CA - Canada 35
IN - India 28
MX - Messico 26
AR - Argentina 23
DE - Germania 23
FI - Finlandia 22
IQ - Iraq 16
ID - Indonesia 14
ES - Italia 13
ZA - Sudafrica 12
NL - Olanda 11
EC - Ecuador 9
PL - Polonia 9
VE - Venezuela 9
JM - Giamaica 8
MA - Marocco 8
SA - Arabia Saudita 8
UA - Ucraina 8
UZ - Uzbekistan 8
JP - Giappone 7
PY - Paraguay 7
AL - Albania 6
CR - Costa Rica 6
PK - Pakistan 6
SE - Svezia 6
CH - Svizzera 5
CL - Cile 5
CO - Colombia 5
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BO - Bolivia 3
EG - Egitto 3
IL - Israele 3
AT - Austria 2
DO - Repubblica Dominicana 2
HN - Honduras 2
NP - Nepal 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CV - Capo Verde 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
YE - Yemen 1
Totale 3.795
Città #
Singapore 247
Ashburn 153
Council Bluffs 139
Hong Kong 98
New York 82
San Jose 79
Los Angeles 64
Milan 58
Columbus 57
Ho Chi Minh City 54
Beijing 52
The Dalles 48
Dallas 42
Lauterbourg 40
Istanbul 34
Buffalo 33
Rome 33
São Paulo 32
Santa Clara 31
Brescia 27
Hanoi 27
Des Moines 23
Phoenix 23
Chicago 22
Moscow 22
Helsinki 17
Atlanta 15
Mexico City 14
Denver 13
Guangzhou 13
Montreal 12
Naples 12
Turin 12
Brooklyn 11
Orem 11
Brasília 9
Chennai 9
Frankfurt am Main 9
London 9
Redondo Beach 9
Rio de Janeiro 9
San Francisco 9
Toronto 9
Warsaw 9
Manchester 8
Tashkent 7
Baghdad 6
Charlotte 6
Curitiba 6
Dhaka 6
Las Vegas 6
Palermo 6
Seattle 6
Stockholm 6
Thái Bình 6
Tokyo 6
Ankara 5
Bari 5
Bologna 5
Bovegno 5
Catania 5
Figino 5
Florence 5
Guayaquil 5
Modena 5
Novo Hamburgo 5
Poplar 5
The Bronx 5
Blumenau 4
Boston 4
Falkenstein 4
Fort Lauderdale 4
Haiphong 4
Hangzhou 4
Houston 4
Johannesburg 4
Kingston 4
Kyiv 4
Munich 4
Nuremberg 4
Padua 4
Paris 4
Philadelphia 4
Porto Alegre 4
Querétaro 4
Riyadh 4
San José 4
Tianjin 4
Tirana 4
Verona 4
Amsterdam 3
Augusta 3
Belo Horizonte 3
Birmingham 3
Biên Hòa 3
Bridgetown 3
Bắc Giang 3
Charleston 3
Da Nang 3
Duhok 3
Totale 1.984
Nome #
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 157
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy 145
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party 140
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients 114
Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic 108
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 108
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma 107
SARS-CoV-2 infection in aplastic anemia 100
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study 96
Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation 95
Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics 94
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles 91
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 88
Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending? 86
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question" 84
CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy 83
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 81
Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience 80
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience 77
A Cellular Therapy with Haploidentical Peripheral Hematopoietic Stem Cell Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease 74
Case report – Prolonged SARS-CoV-2 positive PCR after resolution of symptoms 71
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT 69
Epigenetic Regulation in Myelodysplastic Syndrome as A Consequence of A MicroRNA Dysregulation 68
Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation 68
ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party 68
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 66
A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the “Gut Fitness”? 66
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 65
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 63
Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: A case report 63
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 60
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease 60
Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients 58
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 57
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT 56
Microbial Contamination of Haematopoietic Stem Cell Products: A Single Centre Experience 53
Letter in response to "Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: a Delphi Consensus" 51
Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features 51
Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML) 48
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 46
P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia 44
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 44
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT 44
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 43
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 42
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 40
Systematic screening and focused evaluation for venous occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment 39
Second allogeneic haematopoietic stem cell transplant conditioned with treosulfan and fludarabine is associated with encouraging overall survival and transplant related mortality in late relapse of myeloid malignancies 39
Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study 37
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 36
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 35
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm 34
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 32
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission 24
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid Leukemia 22
Fludarabine-Treosulfan (FT10) Conditioning in Older AML Patients Undergoing Haploidentical Transplantation: A Prospective Italian Study With External Comparison to the Haplo-UK Reduced-Intensity Conditioning Cohort 19
Mogamulizumab as Bridge to Thiotepa-Based Allogeneic Haematopoietic Stem Cell Transplantation in Sézary Syndrome: A Single-Centre Experience 13
Calcineurin inhibitor-induced pain syndrome: an uncommon side effect of immunosuppressive therapy after allogeneic hematopoietic stem cell transplant. a case report and review of the literature 13
Cytokine Release Syndrome after Haploidentical Transplantation is Associated with Improved Survival Without Increasing Transplant-Related Mortality 13
Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCy 11
Correction: Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 (Cancers, (2025), 17, 20, (3278), 10.3390/cancers17203278) 7
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo) 6
Fluoroquinolone-Free Prophylaxis and Impact on Bacterial Infections, Resistance, and Survival in Allo-HSCT: 5-Year Follow-up of the BATMO Protocol (Best Anti-microbical Therapy Trapianto di Midollo Osseo) 6
A Curative-Intent Treatment Programme in Older AML: Mature Post-Transplant Results from the VEN-DEC-GITMO Study 1
Totale 3.859
Categoria #
all - tutte 14.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 1 0 0 0 0
2023/20244 0 0 0 0 0 1 0 0 2 0 0 1
2024/2025661 0 0 35 92 66 55 89 11 49 35 112 117
2025/20262.550 141 244 142 341 208 171 252 152 188 259 233 219
2026/2027643 214 143 185 101 0 0 0 0 0 0 0 0
Totale 3.859